| Financial Year |
March 31 2023 |
| Monetary Funds |
149,113,168.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,546,455.22 |
| Accounts Receivable |
398,338,055.69 |
| Advances to Suppliers |
25,848,512.42 |
| Other Receivables |
6,559,581.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
576,694,618.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,040,665.85 |
| Total Current Assets |
1,203,689,557.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
364,596,675.48 |
| Under-construction Projects |
290,255,755.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
45,660,439.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,343,319.16 |
| Deferred Income Tax Assets |
12,789,492.89 |
| Other Non-Current Assets |
20,637,126.19 |
| Sub-Total of Non-Current Assets |
815,681,321.44 |
| Total Assets |
2,019,370,879.18 |
| Short-Term Loans |
105,185,255.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,581,904.16 |
| Accounts Payable |
436,210,363.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,898,927.48 |
| Taxes Payable |
893,072.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,200,622.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,345,595.38 |
| Other Current Liabilities |
3,086,683.95 |
| Sub-Total of Current Liabilities |
657,064,189.90 |
| Long-term Loans |
31,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
32,092,310.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
76,050,367.11 |
| Total Liabilities |
733,114,557.01 |
| Paid-In Capital(Or Share Stock) |
161,403,600.00 |
| Capital Surplus |
400,504,253.00 |
| Surplus Reserve |
83,605,343.79 |
| LESS:Treasury Stock |
87,410,438.98 |
| Undistributed Profits |
717,134,574.72 |
| Minority Stockholder's Interest |
12,586,861.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,273,669,460.37 |
| Owner's Equity（Stockholder's Equity） |
1,286,256,322.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,019,370,879.18 |
